Hyperfine (HYPR) Share-based Compensation Growth (1y) (2022 - 2026)
Hyperfine (HYPR) Share-based Compensation Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 7.56% |
| 10 | Hyperfine | 88.30 Mn | 43.54 Mn | 1.98 Mn | 65.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.08% |
| Mar 31, 2026 | -31.53% |
| Dec 31, 2025 | -34.35% |
| Sep 30, 2025 | -44.01% |
| Jun 30, 2025 | -53.41% |
| Mar 31, 2025 | -8.43% |
| Dec 31, 2024 | -18.17% |
| Sep 30, 2024 | -7.71% |
| Jun 30, 2024 | 3.62% |
| Mar 31, 2024 | -8.35% |
| Dec 31, 2023 | -28.17% |
| Sep 30, 2023 | 150.72% |
| Jun 30, 2023 | -84.05% |
| Mar 31, 2023 | -72.61% |
| Dec 31, 2022 | 66.02% |
| Sep 30, 2022 | -271.20% |
| Jun 30, 2022 | 376.96% |
| Mar 31, 2022 | 1,439.70% |